The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-κB activation in anaplastic large cell lymphoma

Cancer Cell

Volumn 5, Issue 4, 2004, Pages 353-364

  Horie, Ryouichi ^a,b   Watanabe, Mariko ^b   Ishida, Takaomi ^a   Koiwa, Tsukasa ^a   Aizawa, Shigemi ^a   Itoh, Kinji ^a   Higashihara, Masaaki ^b   Kadin, Marshall E ^c   Watanabe, Toshiki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD30 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEOPLASMIN; ONCOPROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CELL LINE; ENZYME ACTIVITY; LARGE CELL LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 1842785805     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(04)00084-4     Document Type: Article

References (55)

1. Aizawa S., Nakano H., Ishida T., Horie R., Nagai M., Ito K., Yagita H., Okumura K., Inoue J., Watanabe T. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFκB activation. J. Biol. Chem. 272:1997;2042-2045.
2. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:1991;2499.
3. Bai R.Y., Dieter P., Peschel C., Morris S.W., Duyster J. Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-γ to mediate its mitogenicity. Mol. Cell. Biol. 18:1998;6951-6961.
4. Bargou R.C., Leng C., Krappmann D., Emmerich F., Mapara M.Y., Bommert K., Royer H.D., Scheidereit C., Dorken B. High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood. 87:1996;4340-4347.
5. Baud V., Liu Z.G., Bennett B., Suzuki N., Xia Y., Karin M. Signaling by proinflammatory cytokines. Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain Genes Dev. 13:1999;1297-1308.
6. Beg A.A., Baltimore D. An essential role for NF-κB in preventing TNF-alpha-induced cell death. Science. 274:1996;782-784.
7. Bischof D., Pulford K., Mason D.Y., Morris S.W. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol. Cell. Biol. 17:1997;2312-2325.
8. Borer R.A., Lehner C.F., Eppenberger H.M., Nigg E.A. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell. 56:1989;379-390.
9. Chiarle R., Podda A., Prolla G., Gong J., Thorbecke G.J., Inghirami G. CD30 in normal and neoplastic cells. Clin. Immunol. 90:1999;157-164.
10. Chiarle R., Gong J.Z., Guasparri I., Pesci A., Cai J., Liu J., Simmons W.J., Dhall G., Howes J., Piva R., Inghirami G. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood. 101:2003;1919-1927.
11. Dyomin V.G., Palanisamy N., Lloyd K.O., Dyomina K., Jhanwar S.C., Houldsworth J., Chaganti R.S. MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets. Blood. 95:2000;2666-2671.
12. Fujimoto J., Shiota M., Iwahara T., Seki N., Satoh H., Mori S., Yamamoto T. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc. Natl. Acad. Sci. USA. 93:1996;4181-4186.
13. Gonzalez-Guerrico A.M., Cafferata E.G., Radrizzani M., Marcucci F., Gruenert D., Pivetta O.H., Favaloro R.R., Laguens R., Perrone S.V., Gallo G.C., Santa-Coloma T.A. Tyrosine kinase c-Src constitutes a bridge between cystic fibrosis transmembrane regulator channel failure and MUC1 overexpression in cystic fibrosis. J. Biol. Chem. 277:2002;17239-17247.
14. Hernandez L., Pinyol M., Hernandez S., Bea S., Pulford K., Rosenwald A., Lamant L., Falini B., Ott G., Mason D.Y.et al. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood. 94:1999;3265-3268.
15. Hingorani K., Szebeni A., Olson M.O. Mapping the functional domains of nucleolar protein B23. J. Biol. Chem. 275:2000;24451-24457.
16. Horie R., Watanabe T. CD30. Expression and function in health and disease Semin. Immunol. 10:1998;457-470.
17. Horie R., Ito K., Tatewaki M., Nagai M., Aizawa S., Higashihara M., Ishida T., Inoue J., Takizawa H., Watanabe T. A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages. Blood. 88:1996;2422-2432.
18. Horie R., Aizawa S., Nagai M., Ito K., Higashihara M., Ishida T., Inoue J., Watanabe T. A novel domain in the CD30 cytoplasmic tail mediates NFκB activation. Int. Immunol. 10:1998;203-210.
19. Horie R., Watanabe T., Ito K., Morisita Y., Watanabe M., Ishida T., Higashihara M., Kadin M., Watanabe T. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in Hodgkin-Reed-Sternberg Cells. Am. J. Pathol. 160:2002;1647-1654. a.
20. Horie R., Watanabe T., Morishita Y., Ito K., Ishida T., Kanegae Y., Saito I., Higashihara M., Mori S., Kadin M.E., Watanabe T. Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin-Reed-Sternberg cells. Oncogene. 21:2002;2493-2503. b.
21. Horie R., Higashihara M., Watanabe T. Hodgkin's lymphoma and CD30 signal transduction. Int. J. Hematol. 77:2003;37-47.
22. Hubinger G., Muller E., Scheffrahn I., Schneider C., Hildt E., Singer B.B., Sigg I., Graf J., Bergmann L. CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299. Oncogene. 20:2001;590-598.
23. Inoue J., Ishida T., Tsukamoto N., Kobayashi N., Naito A., Azuma S., Yamamoto T. Tumor necrosis factor receptor-associated factor (TRAF) family. Adapter proteins that mediate cytokine signaling Exp. Cell Res. 254:2000;14-24.
24. Iwahara T., Fujimoto J., Wen D., Cupples R., Bucay N., Arakawa T., Mori S., Ratzkin B., Yamamoto T. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene. 14:1997;439-449.
25. Jaffe E.S. Anaplastic large cell lymphoma. The shifting sands of diagnostic hematopathology Mod. Pathol. 14:2001;219-228.
26. Kadin M.E. Ki-1/CD30+ (anaplastic) large-cell lymphoma. maturation of a clinicopathologic entity with prospects of effective therapy J. Clin. Oncol. 12:1994;884-887.
27. Kadin M.E., Drews R., Samel A., Gilchrist A., Kocher O. Hodgkin's lymphoma of T-cell type. Clonal association with a CD30+ cutaneous lymphoma Hum. Pathol. 32:2001;1269-1272.
28. Kunkel T.A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA. 82:1985;488-492.
29. Lae M.E., Ahmed I., Macon W.R. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma. Am. J. Clin. Pathol. 118:2002;773-779.
30. Lamant L., Dastugue N., Pulford K., Delsol G., Mariame B. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood. 93:1999;3088-3095.
31. Leoncini L., Del Vecchio M.T., Kraft R., Megha T., Barbini P., Cevenini G., Poggi S., Pileri S., Tosi P., Cottier H. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas-a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am. J. Pathol. 137:1990;1047-1057.
32. Levi E., Pfeifer W.M., Kadin M.E. CD30-activation-mediated growth inhibition of anaplastic large-cell lymphoma cell lines. Apoptosis or cell-cycle arrest? Blood. 98:2001;1630-1632.
33. Malinin N.L., Boldin M.P., Kovalenko A.V., Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544.
34. Minden A., Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta. 1333:1997;F85-104.
35. Mir S.S., Richter B.W., Duckett C.S. Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells. Blood. 96:2000;4307-4312.
36. Morris S.W., Kirstein M.N., Valentine M.B., Dittmer K.G., Shapiro D.N., Saltman D.L., Look A.T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 263:1994;1281-1284.
37. Muschen M., Rajewsky K., Brauninger A., Baur A.S., Oudejans J.J., Roers A., Hansmann M.L., Kuppers R. Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J. Exp. Med. 191:2000;387-394.
38. Nishitoh H., Saitoh M., Mochida Y., Takeda K., Nakano H., Rothe M., Miyazono K., Ichijo H. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell. 2:1998;389-395.
39. Okuda M., Horn H.F., Tarapore P., Tokuyama Y., Smulian A.G., Chan P.K., Knudsen E.S., Hofmann I.A., Snyder J.D., Bove K.E., Fukasawa K. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell. 103:2000;127-140.
40. Olson M.O., Wallace M.O., Herrera A.H., Marshall-Carlson L., Hunt R.C. Preribosomal ribonucleoprotein particles are a major component of a nucleolar matrix fraction. Biochemistry. 25:1986;484-491.
41. Saffer H., Wahed A., Rassidakis G.Z., Medeiros L.J. Clusterin expression in malignant lymphomas. A survey of 266 cases Mod. Pathol. 15:2002;1221-1226.
42. Schneider C., Hubinger G. Pleiotropic signal transduction mediated by human CD30. A member of the tumor necrosis factor receptor (TNFR) family Leuk. Lymphoma. 43:2002;1355-1366.
43. Scibetta A.G., Albanese I., Morris J., Cooper L., Downward J., Rowe P.P., Taylor-Papadimitriou J. Regulation of MUC1 expression in human mammary cell lines by the c-ErbB2 and ras signaling pathways. DNA Cell Biol. 20:2001;265-274.
44. Seitz V., Hummel M., Marafioti T., Anagnostopoulos I., Assaf C., Stein H. Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood. 95:2000;3020-3024.
45. Stein H., Foss H.D., Durkop H., Marafioti T., Delsol G., Pulford K., Pileri S., Falini B. CD30(+) anaplastic large cell lymphoma. A review of its histopathologic, genetic, and clinical features Blood. 96:2000;3681-3695.
46. Szebeni A., Olson M.O. Nucleolar protein B23 has molecular chaperone activities. Protein Sci. 8:1999;905-912.
47. Szebeni A., Hingorani K., Negi S., Olson M.O. Role of protein kinase CK2 phosphorylation in the molecular chaperone activity of nucleolar protein b23. J. Biol. Chem. 278:2003;9107-9115.
48. Treon S.P., Mollick J.A., Urashima M., Teoh G., Chauhan D., Ogata A., Raje N., Hilgers J.H., Nadler L., Belch A.R.et al. Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone. Blood. 93:1999;1287-1298.
49. Wajant H., Henkler F., Scheurich P. The TNF-receptor-associated factor family. Scaffold molecules for cytokine receptors, kinases and their regulators Cell. Signal. 13:2001;389-400.
50. Wakimoto H., Yoshida Y., Aoyagi M., Hirakawa K., Hamada H. Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy. Jpn. J. Cancer Res. 88:1997;296-305.
51. Watanabe M., Ogawa Y., Ito K., Higashihara M., Kadin M.E., Abraham L.J., Watanabe T., Horie R. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells. Am. J. Pathol. 163:2003;633-641.
52. Wellmann A., Doseeva V., Butscher W., Raffeld M., Fukushima P., Stetler-Stevenson M., Gardner K. The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up-regulation in rat 1a fibroblasts. FASEB J. 11:1997;965-972.
53. Wellmann A., Thieblemont C., Pittaluga S., Sakai A., Jaffe E.S., Siebert P., Raffeld M. Detection of differentially expressed genes in lymphomas using cDNA arrays. identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas Blood. 96:2000;398-404.
54. Willers J., Dummer R., Kempf W., Kundig T., Burg G., Kadin M.E. Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand. Clin. Cancer Res. 9:2003;2744-2754.
55. Ye H., Park Y.C., Kreishman M., Kieff E., Wu H. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol. Cell. 4:1999;321-330.